Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05319171
Other study ID # 12345
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2022
Est. completion date November 2022

Study information

Verified date March 2022
Source IRCCS Policlinico S. Donato
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

- To investigate the performance of currently available THVs in terms of safety and efficacy - To evaluate potential predictors of THV embolization or migration (TVEM) - To assess the impact of TVEM on prognosis


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date November 2022
Est. primary completion date October 2022
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - severe aortic regurgitation - prohibitive surgical risk Exclusion Criteria: - surgical candidates

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TAVR
TAVR

Locations

Country Name City State
Italy IRCCS Policlinico S. Donato, Milan, Italy Milano Milan

Sponsors (1)

Lead Sponsor Collaborator
IRCCS Policlinico S. Donato

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall mortality 1 year
See also
  Status Clinical Trial Phase
Completed NCT03314857 - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population N/A
Completed NCT03666351 - Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease Phase 4
Recruiting NCT06034028 - J-Valve TF Early Feasibility Study N/A
Completed NCT05515848 - Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David
Active, not recruiting NCT03549091 - Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI N/A
Completed NCT01598844 - JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation
Active, not recruiting NCT03466918 - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population N/A
Active, not recruiting NCT04415047 - The JenaValve ALIGN-AR Pivotal Trial N/A
Completed NCT05774795 - LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
Terminated NCT02351726 - Mitroflow DL Post Approval Study- North America N/A
Completed NCT00624884 - Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation N/A
Withdrawn NCT05409378 - HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation N/A
Recruiting NCT04038879 - Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
Completed NCT05332184 - Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
Completed NCT01400841 - HAART Model 300 Annuloplasty Ring N/A
Not yet recruiting NCT02633423 - Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery N/A
Completed NCT00976625 - Diastolic Dysfunction in Aortic Regurgitation N/A
Enrolling by invitation NCT05714293 - CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement. N/A
Recruiting NCT02974920 - Rivaroxaban or Aspirin for Biological Aortic Prosthesis Phase 4
Not yet recruiting NCT03788590 - Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System N/A